1	The	The	B-NP	DT	O	2	NMOD	-1
2	role	role	I-NP	NN	O	0	ROOT	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	organ	organ	B-NP	NN	O	5	NMOD	-1
5	vascularization	vascularization	I-NP	NN	O	9	NMOD	3	vascularization
6	and	and	O	CC	O	9	NMOD	-1
7	lipoplex-serum	lipoplex-serum	B-NP	NN	O	9	NMOD	-1
8	initial	initial	I-NP	JJ	O	9	NMOD	-1
9	contact	contact	I-NP	NN	O	3	PMOD	0
10	in	in	B-PP	IN	O	2	NMOD	-1
11	intravenous	intravenous	B-NP	JJ	O	13	NMOD	-1
12	murine	murine	I-NP	JJ	O	13	NMOD	-1
13	lipofection	lipofection	I-NP	NN	O	10	PMOD	19	lipofection
14	.	.	O	.	O	2	P	-1

1	Following	Follow	B-VP	VBG	O	18	VMOD	-1
2	intravenous	intravenous	B-NP	JJ	O	3	NMOD	-1
3	administration	administration	I-NP	NN	O	1	OBJ	19	administration
4	of	of	B-PP	IN	O	3	NMOD	-1
5	cationic	cationic	B-NP	JJ	B-protein	7	NMOD	-1
6	lipid-DNA	lipid-DNA	I-NP	NN	I-protein	7	NMOD	-1
7	complexes	complex	I-NP	NNS	I-protein	4	PMOD	-1
8	(	(	O	(	O	10	DEP	-1
9	lipoplexes	lipoplex	B-NP	NNS	O	10	DEP	-1
10	)	)	O	)	O	7	NMOD	-1
11	into	into	B-PP	IN	O	1	VMOD	-1
12	mice	mouse	B-NP	NNS	O	11	PMOD	-1
13	,	,	O	,	O	18	P	-1
14	transfection	transfection	B-NP	NN	O	18	SUB	0
15	(	(	O	(	O	17	DEP	-1
16	lipofection	lipofection	B-NP	NN	O	17	DEP	0
17	)	)	O	)	O	14	NMOD	-1
18	occurs	occur	B-VP	VBZ	O	0	ROOT	-1
19	predominantly	predominantly	B-ADVP	RB	O	18	VMOD	-1
20	in	in	B-PP	IN	O	18	VMOD	-1
21	the	the	B-NP	DT	O	22	NMOD	-1
22	lungs	lung	I-NP	NNS	O	20	PMOD	-1
23	.	.	O	.	O	18	P	-1

1	This	This	B-NP	DT	O	2	SUB	-1
2	was	be	B-VP	VBD	O	0	ROOT	-1
3	attributed	attribute	I-VP	VBN	O	2	VC	-1
4	to	to	B-PP	TO	O	3	VMOD	-1
5	high	high	B-NP	JJ	O	6	NMOD	-1
6	entrapment	entrapment	I-NP	NN	O	4	PMOD	14	entrapment
7	of	of	B-PP	IN	O	6	NMOD	-1
8	lipoplexes	lipoplex	B-NP	NNS	O	7	PMOD	-1
9	in	in	B-PP	IN	O	6	NMOD	-1
10	the	the	B-NP	DT	O	14	NMOD	-1
11	extended	extend	I-NP	VBN	O	14	NMOD	0
12	lung	lung	I-NP	NN	O	14	NMOD	-1
13	vascular	vascular	I-NP	JJ	O	14	NMOD	-1
14	tree	tree	I-NP	NN	O	9	PMOD	-1
15	.	.	O	.	O	2	P	-1

1	To	To	B-VP	TO	O	2	VMOD	-1
2	determine	determine	I-VP	VB	O	19	VMOD	-1
3	whether	whether	B-SBAR	IN	O	2	VMOD	-1
4	lipofection	lipofection	B-NP	NN	O	8	SUB	19	lipofection
5	in	in	B-PP	IN	O	4	NMOD	-1
6	other	other	B-NP	JJ	O	7	NMOD	-1
7	organs	organ	I-NP	NNS	O	5	PMOD	-1
8	could	could	B-VP	MD	O	3	SBAR	-1
9	be	be	I-VP	VB	O	8	VC	-1
10	enhanced	enhance	I-VP	VBN	O	9	VC	17	enhanced
11	by	by	B-PP	IN	O	10	VMOD	-1
12	increasing	increase	B-VP	VBG	O	11	PMOD	17	increasing
13	the	the	B-NP	DT	O	14	NMOD	-1
14	degree	degree	I-NP	NN	O	12	OBJ	-1
15	of	of	B-PP	IN	O	14	NMOD	-1
16	vascularization	vascularization	B-NP	NN	O	15	PMOD	3	vascularization
17	,	,	O	,	O	19	P	-1
18	we	we	B-NP	PRP	O	19	SUB	-1
19	used	use	B-VP	VBD	O	0	ROOT	0
20	a	a	B-NP	DT	O	23	NMOD	-1
21	transgenic	transgenic	I-NP	JJ	O	23	NMOD	0
22	mouse	mouse	I-NP	NN	O	23	NMOD	-1
23	model	model	I-NP	NN	O	19	OBJ	-1
24	with	with	B-PP	IN	O	23	NMOD	-1
25	tissue-specific	tissue-specific	B-NP	JJ	O	26	NMOD	-1
26	angiogenesis	angiogenesis	I-NP	NN	O	24	PMOD	3	angiogenesis
27	in	in	B-PP	IN	O	26	NMOD	-1
28	liver	liver	B-NP	NN	O	27	PMOD	-1
29	.	.	O	.	O	19	P	-1

1	Tail	Tail	B-NP	NN	O	3	NMOD	-1
2	vein	vein	I-NP	NN	O	3	NMOD	-1
3	injection	injection	I-NP	NN	O	26	SUB	19	injection
4	of	of	B-PP	IN	O	3	NMOD	-1
5	N-	N-	B-NP	NN	O	15	NMOD	-1
6	(	(	O	(	O	14	DEP	-1
7	1-	1-	B-NP	CD	O	14	DEP	-1
8	(	(	O	(	O	14	DEP	-1
9	2	2	B-NP	CD	O	13	NMOD	-1
10	,	,	O	,	O	13	P	-1
11	3-dioleoyloxy	3-dioleoyloxy	B-ADJP	JJ	O	13	NMOD	-1
12	)	)	O	)	O	13	NMOD	-1
13	propyl	propyl	B-NP	NN	O	14	DEP	-1
14	)	)	O	)	O	5	NMOD	-1
15	-N	-N	B-NP	NN	O	25	NMOD	-1
16	,	,	O	,	O	25	P	-1
17	N	N	B-NP	NN	O	25	NMOD	-1
18	,	,	O	,	O	25	P	-1
19	N-trimethylammonium	N-trimethylammonium	B-NP	NN	B-protein	25	NMOD	-1
20	chloride	chloride	I-NP	NN	I-protein	25	NMOD	-1
21	(	(	O	(	I-protein	25	NMOD	-1
22	DOTAP	DOTAP	B-NP	NN	I-protein	25	NMOD	-1
23	)	)	O	)	I-protein	25	NMOD	-1
24	/cholesterol	/cholesterol	B-NP	NN	I-protein	25	NMOD	-1
25	lipoplexes	lipoplex	I-NP	NNS	I-protein	4	PMOD	-1
26	resulted	result	B-VP	VBD	O	0	ROOT	17	resulted
27	in	in	B-PP	IN	O	26	VMOD	-1
28	increased	increase	B-NP	VBN	O	30	NMOD	17	increased
29	lipoplex	lipoplex	I-NP	NN	O	30	NMOD	-1
30	entrapment	entrapment	I-NP	NN	O	27	PMOD	14	entrapment
31	in	in	B-PP	IN	O	30	NMOD	-1
32	hypervascularized	hypervascularize	B-NP	VBN	O	33	NMOD	-1
33	liver	liver	I-NP	NN	O	31	PMOD	-1
34	but	but	O	CC	O	26	VMOD	-1
35	did	do	B-VP	VBD	O	26	VMOD	-1
36	not	not	I-VP	RB	O	35	VMOD	-1
37	boost	boost	I-VP	VB	O	35	VC	17	boost
38	luciferase	luciferase	B-NP	NN	B-protein	39	NMOD	-1
39	expression	expression	I-NP	NN	O	37	OBJ	9	expression
40	,	,	O	,	O	26	P	-1
41	suggesting	suggest	B-VP	VBG	O	26	VMOD	-1
42	that	that	B-SBAR	IN	O	41	VMOD	-1
43	lipoplex	lipoplex	B-NP	NN	O	44	NMOD	-1
44	delivery	delivery	I-NP	NN	O	45	SUB	14	delivery
45	is	be	B-VP	VBZ	O	42	SBAR	-1
46	not	not	O	RB	O	45	VMOD	-1
47	a	a	B-NP	DT	O	49	NMOD	-1
48	sufficient	sufficient	I-NP	JJ	O	49	NMOD	17	sufficient
49	condition	condition	I-NP	NN	O	45	PRD	-1
50	for	for	B-PP	IN	O	49	NMOD	-1
51	efficient	efficient	B-NP	JJ	O	53	NMOD	-1
52	organ	organ	I-NP	NN	O	53	NMOD	-1
53	lipofection	lipofection	I-NP	NN	O	50	PMOD	19	lipofection
54	.	.	O	.	O	26	P	-1

1	Because	Because	B-SBAR	IN	O	13	VMOD	-1
2	the	the	B-NP	DT	O	5	NMOD	-1
3	intravenously	intravenously	I-NP	RB	O	4	AMOD	-1
4	injected	inject	I-NP	VBN	O	5	NMOD	19	injected
5	lipoplexes	lipoplex	I-NP	NNS	O	6	SUB	-1
6	migrated	migrate	B-VP	VBD	O	1	SBAR	14	migrated
7	within	within	B-PP	IN	O	6	VMOD	-1
8	seconds	second	B-NP	NNS	O	7	PMOD	-1
9	to	to	B-PP	TO	O	8	NMOD	-1
10	lungs	lung	B-NP	NNS	O	9	PMOD	-1
11	,	,	O	,	O	13	P	-1
12	we	we	B-NP	PRP	O	13	SUB	-1
13	checked	check	B-VP	VBD	O	0	ROOT	-1
14	whether	whether	B-SBAR	IN	O	13	VMOD	-1
15	the	the	B-NP	DT	O	16	NMOD	-1
16	effects	effect	I-NP	NNS	O	22	SUB	0
17	of	of	B-PP	IN	O	16	NMOD	-1
18	immediate	immediate	B-NP	JJ	O	19	NMOD	-1
19	contact	contact	I-NP	NN	O	17	PMOD	0
20	with	with	B-PP	IN	O	16	NMOD	-1
21	serum	serum	B-NP	NN	O	20	PMOD	-1
22	correlate	correlate	B-VP	VBP	O	14	SBAR	-1
23	with	with	B-PP	IN	O	22	VMOD	-1
24	lung	lung	B-NP	NN	O	26	NMOD	-1
25	lipofection	lipofection	I-NP	NN	O	26	NMOD	19	lipofection
26	efficiency	efficiency	I-NP	NN	O	23	PMOD	-1
27	of	of	B-PP	IN	O	26	NMOD	-1
28	different	different	B-NP	JJ	O	29	AMOD	-1
29	DOTAP-based	DOTAP-based	I-NP	JJ	O	30	NMOD	-1
30	formulations	formulation	I-NP	NNS	O	27	PMOD	-1
31	.	.	O	.	O	13	P	-1

1	Under	Under	B-PP	IN	O	11	VMOD	-1
2	conditions	condition	B-NP	NNS	O	1	PMOD	-1
3	mimicking	mimic	B-VP	VBG	O	2	NMOD	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	injection	injection	I-NP	NN	O	6	NMOD	0
6	environment	environment	I-NP	NN	O	3	OBJ	-1
7	,	,	O	,	O	11	P	-1
8	the	the	B-NP	DT	O	10	NMOD	-1
9	lipoplex-serum	lipoplex-serum	I-NP	NN	O	10	NMOD	-1
10	interaction	interaction	I-NP	NN	O	11	SUB	0
11	was	be	B-VP	VBD	O	0	ROOT	-1
12	strongly	strongly	B-ADJP	RB	O	13	AMOD	-1
13	dependent	dependent	I-ADJP	JJ	O	11	PRD	0
14	on	on	B-PP	IN	O	13	AMOD	-1
15	helper	helper	B-NP	NN	O	16	NMOD	-1
16	lipid	lipid	I-NP	NN	O	19	NMOD	-1
17	and	and	O	CC	O	19	NMOD	-1
18	ionic	ionic	B-NP	JJ	O	19	NMOD	-1
19	strength	strength	I-NP	NN	O	14	PMOD	-1
20	:	:	O	:	O	11	P	-1
21	lipoplexes	lipoplex	B-NP	NNS	O	11	VMOD	-1
22	prepared	prepare	B-VP	VBN	O	21	NMOD	-1
23	in	in	B-PP	IN	O	22	VMOD	-1
24	150	150	B-NP	CD	O	26	NMOD	-1
25	mM	mM	I-NP	NN	O	26	NMOD	-1
26	NaCl	NaCl	I-NP	NN	O	28	NMOD	-1
27	or	or	O	CC	O	28	NMOD	-1
28	lipoplexes	lipoplex	B-NP	NNS	O	23	PMOD	-1
29	with	with	B-PP	IN	O	28	NMOD	-1
30	high	high	B-NP	JJ	O	29	PMOD	-1
31	(	(	O	(	O	30	NMOD	-1
32	greater	great	B-ADJP	JJR	O	39	SUB	-1
33	than	than	B-PP	IN	O	32	AMOD	-1
34	33	33	B-NP	CD	O	35	AMOD	-1
35	mol	mol	I-NP	NN	O	38	NMOD	-1
36	%	%	I-NP	NN	O	38	NMOD	-1
37	)	)	O	)	O	38	NMOD	-1
38	cholesterol	cholesterol	B-NP	NN	O	33	PMOD	-1
39	were	be	B-VP	VBD	O	31	SBAR	-1
40	found	find	I-VP	VBN	O	39	VC	0
41	to	to	I-VP	TO	O	42	VMOD	-1
42	aggregate	aggregate	I-VP	VB	O	40	VMOD	15	aggregate
43	immediately	immediately	B-ADVP	RB	O	42	VMOD	-1
44	.	.	O	.	O	11	P	-1

1	This	This	B-NP	DT	O	3	NMOD	-1
2	aggregation	aggregation	I-NP	NN	O	3	NMOD	15	aggregation
3	process	process	I-NP	NN	O	4	SUB	-1
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	irreversible	irreversible	B-ADJP	JJ	O	4	PRD	-1
6	and	and	O	CC	O	4	VMOD	-1
7	was	be	B-VP	VBD	O	4	VMOD	-1
8	inversely	inversely	I-VP	RB	O	7	VMOD	-1
9	correlated	correlate	I-VP	VBN	O	7	VC	-1
10	with	with	B-PP	IN	O	9	VMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	percentage	percentage	I-NP	NN	O	10	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	lung	lung	B-NP	NN	B-cell_type	15	NMOD	-1
15	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	-1
16	that	that	B-NP	WDT	O	15	NMOD	-1
17	took	take	B-VP	VBD	O	16	SBAR	-1
18	up	up	B-PRT	RP	O	17	VMOD	-1
19	lipoplexes	lipoplex	B-NP	NNS	O	17	VMOD	-1
20	and	and	B-PP	CC	O	19	NMOD	-1
21	with	with	B-PP	IN	O	20	PMOD	-1
22	the	the	B-NP	DT	O	23	NMOD	-1
23	efficiency	efficiency	I-NP	NN	O	21	PMOD	-1
24	of	of	B-PP	IN	O	23	NMOD	-1
25	lipofection	lipofection	B-NP	NN	O	24	PMOD	19	lipofection
26	.	.	O	.	O	4	P	-1

1	No	No	B-NP	DT	O	4	NMOD	-1
2	other	other	I-NP	JJ	O	4	NMOD	-1
3	structural	structural	I-NP	JJ	O	4	NMOD	-1
4	changes	change	I-NP	NNS	O	7	SUB	0
5	in	in	B-PP	IN	O	4	NMOD	-1
6	serum	serum	B-NP	NN	O	5	PMOD	-1
7	were	be	B-VP	VBD	O	0	ROOT	-1
8	observed	observe	I-VP	VBN	O	7	VC	0
9	for	for	B-PP	IN	O	8	VMOD	-1
10	cholesterol-based	cholesterol-based	B-NP	JJ	O	11	NMOD	-1
11	lipoplexes	lipoplex	I-NP	NNS	O	9	PMOD	-1
12	.	.	O	.	O	7	P	-1

1	Dioleoyl	Dioleoyl	B-NP	NN	O	3	NMOD	-1
2	phosphatidylethanolamine-based	phosphatidylethanolamine-based	I-NP	JJ	O	3	NMOD	-1
3	lipoplexes	lipoplex	I-NP	NNS	O	4	SUB	-1
4	were	be	B-VP	VBD	O	0	ROOT	-1
5	found	find	I-VP	VBN	O	4	VC	0
6	to	to	I-VP	TO	O	7	VMOD	-1
7	give	give	I-VP	VB	O	5	VMOD	-1
8	low	low	B-NP	JJ	O	9	NMOD	-1
9	expression	expression	I-NP	NN	O	7	OBJ	0
10	,	,	O	,	O	7	P	-1
11	apparently	apparently	B-ADVP	RB	O	12	PMOD	-1
12	because	because	B-PP	IN	O	7	VMOD	-1
13	of	of	I-PP	IN	O	12	PMOD	-1
14	an	an	B-NP	DT	O	16	NMOD	-1
15	immediate	immediate	I-NP	JJ	O	16	NMOD	-1
16	loss	loss	I-NP	NN	O	12	PMOD	0
17	of	of	B-PP	IN	O	16	NMOD	-1
18	integrity	integrity	B-NP	NN	O	17	PMOD	-1
19	in	in	B-PP	IN	O	16	NMOD	-1
20	serum	serum	B-NP	NN	O	19	PMOD	-1
21	,	,	O	,	O	16	P	-1
22	without	without	B-PP	IN	O	16	NMOD	-1
23	lipid-DNA	lipid-DNA	B-NP	NN	O	24	NMOD	-1
24	dissociation	dissociation	I-NP	NN	O	22	PMOD	-1
25	.	.	O	.	O	4	P	-1

1	Our	Our	B-NP	PRP$	O	2	NMOD	-1
2	study	study	I-NP	NN	O	3	SUB	-1
3	suggests	suggest	B-VP	VBZ	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	efficient	efficient	B-NP	JJ	O	8	NMOD	-1
6	in	in	I-NP	FW	O	7	AMOD	-1
7	vivo	vivo	I-NP	FW	O	8	NMOD	-1
8	lipofection	lipofection	I-NP	NN	O	9	SUB	0
9	is	be	B-VP	VBZ	O	4	SBAR	-1
10	the	the	B-NP	DT	O	11	NMOD	-1
11	result	result	I-NP	NN	O	9	PRD	-1
12	of	of	B-PP	IN	O	11	NMOD	-1
13	cross-talk	cross-talk	B-NP	NN	O	28	NMOD	-1
14	between	between	B-PP	IN	O	13	NMOD	-1
15	lipoplex	lipoplex	B-NP	NN	O	16	NMOD	-1
16	composition	composition	I-NP	NN	O	14	PMOD	-1
17	,	,	O	,	O	28	P	-1
18	interaction	interaction	B-NP	NN	O	28	NMOD	0
19	with	with	B-PP	IN	O	18	NMOD	-1
20	serum	serum	B-NP	NN	O	19	PMOD	-1
21	,	,	O	,	O	28	P	-1
22	hemodynamics	hemodynamic	B-NP	NNS	O	28	NMOD	-1
23	,	,	O	,	O	28	P	-1
24	and	and	O	CC	O	28	NMOD	-1
25	target	target	B-NP	NN	O	28	NMOD	0
26	tissue	tissue	I-NP	NN	O	28	NMOD	-1
27	``	``	B-NP	``	O	28	NMOD	-1
28	susceptibility	susceptibility	I-NP	NN	O	12	PMOD	-1
29	''	''	O	''	O	28	NMOD	-1
30	to	to	B-PP	TO	O	28	NMOD	-1
31	transfection	transfection	B-NP	NN	O	30	PMOD	0
32	.	.	O	.	O	3	P	-1

